Cargando…
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986575/ https://www.ncbi.nlm.nih.gov/pubmed/29880982 http://dx.doi.org/10.1055/a-0594-2243 |
_version_ | 1783328951867801600 |
---|---|
author | Untch, Michael Würstlein, Rachel Marschner, Norbert Lüftner, Diana Augustin, Doris Briest, Susanne Ettl, Johannes Haidinger, Renate Müller, Lothar Müller, Volkmar Ruckhäberle, Eugen Harbeck, Nadia Thomssen, Christoph |
author_facet | Untch, Michael Würstlein, Rachel Marschner, Norbert Lüftner, Diana Augustin, Doris Briest, Susanne Ettl, Johannes Haidinger, Renate Müller, Lothar Müller, Volkmar Ruckhäberle, Eugen Harbeck, Nadia Thomssen, Christoph |
author_sort | Untch, Michael |
collection | PubMed |
description | The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in the text. In clinical practice, the abbreviation corresponds to metastatic breast cancer or locally far-advanced disease. This year the focus was on new developments in the treatment of ABC. Topics discussed included the importance of CDK4/6 inhibition in hormone receptor (HR)-positive ABC, the use of dual antibody blockade to treat HER2-positive ABC, PARP inhibition in triple-negative ABC and the potential therapeutic outcomes. Another major area discussed at the conference was BRCA-associated breast cancer, the treatment of cerebral metastasis, and individualized treatment decisions based on molecular testing (so-called precision medicine). As in previous years, close cooperation with representatives from patient organizations from around the world is an important aspect of the ABC conference. This cooperation was reinforced and expanded at the ABC4 conference. A global alliance was founded at the conclusion of the consensus conference, which aims to promote and coordinate the measures considered necessary by patient advocates worldwide. Because the panel of experts was composed of specialists from all over the world, it was inevitable that the ABC consensus also reflected country-specific features. As in previous years, a team of German breast cancer specialists who closely followed the consensus voting of the ABC panelists in Lisbon and intensively discussed the votes has therefore commented on the consensus in the context of the current German guidelines on the diagnosis and treatment of breast cancer 1 , 2 used in clinical practice in Germany. The ABC consensus is based on the votes of the ABC panelists in Lisbon. |
format | Online Article Text |
id | pubmed-5986575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-59865752018-06-05 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts Untch, Michael Würstlein, Rachel Marschner, Norbert Lüftner, Diana Augustin, Doris Briest, Susanne Ettl, Johannes Haidinger, Renate Müller, Lothar Müller, Volkmar Ruckhäberle, Eugen Harbeck, Nadia Thomssen, Christoph Geburtshilfe Frauenheilkd The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in the text. In clinical practice, the abbreviation corresponds to metastatic breast cancer or locally far-advanced disease. This year the focus was on new developments in the treatment of ABC. Topics discussed included the importance of CDK4/6 inhibition in hormone receptor (HR)-positive ABC, the use of dual antibody blockade to treat HER2-positive ABC, PARP inhibition in triple-negative ABC and the potential therapeutic outcomes. Another major area discussed at the conference was BRCA-associated breast cancer, the treatment of cerebral metastasis, and individualized treatment decisions based on molecular testing (so-called precision medicine). As in previous years, close cooperation with representatives from patient organizations from around the world is an important aspect of the ABC conference. This cooperation was reinforced and expanded at the ABC4 conference. A global alliance was founded at the conclusion of the consensus conference, which aims to promote and coordinate the measures considered necessary by patient advocates worldwide. Because the panel of experts was composed of specialists from all over the world, it was inevitable that the ABC consensus also reflected country-specific features. As in previous years, a team of German breast cancer specialists who closely followed the consensus voting of the ABC panelists in Lisbon and intensively discussed the votes has therefore commented on the consensus in the context of the current German guidelines on the diagnosis and treatment of breast cancer 1 , 2 used in clinical practice in Germany. The ABC consensus is based on the votes of the ABC panelists in Lisbon. Georg Thieme Verlag KG 2018-05 2018-06-04 /pmc/articles/PMC5986575/ /pubmed/29880982 http://dx.doi.org/10.1055/a-0594-2243 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Untch, Michael Würstlein, Rachel Marschner, Norbert Lüftner, Diana Augustin, Doris Briest, Susanne Ettl, Johannes Haidinger, Renate Müller, Lothar Müller, Volkmar Ruckhäberle, Eugen Harbeck, Nadia Thomssen, Christoph 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts |
title |
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
: ABC4 Consensus: Assessment by a Panel of German Experts |
title_full |
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
: ABC4 Consensus: Assessment by a Panel of German Experts |
title_fullStr |
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
: ABC4 Consensus: Assessment by a Panel of German Experts |
title_full_unstemmed |
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
: ABC4 Consensus: Assessment by a Panel of German Experts |
title_short |
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017
: ABC4 Consensus: Assessment by a Panel of German Experts |
title_sort | 4th international consensus conference on advanced breast cancer (abc4), lisbon, november 4, 2017
: abc4 consensus: assessment by a panel of german experts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986575/ https://www.ncbi.nlm.nih.gov/pubmed/29880982 http://dx.doi.org/10.1055/a-0594-2243 |
work_keys_str_mv | AT untchmichael 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT wurstleinrachel 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT marschnernorbert 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT luftnerdiana 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT augustindoris 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT briestsusanne 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT ettljohannes 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT haidingerrenate 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT mullerlothar 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT mullervolkmar 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT ruckhaberleeugen 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT harbecknadia 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts AT thomssenchristoph 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts |